The U.S. has invested over two and a half times more than the EU and three European countries. [© Orlando Florin Rosu - Fotolia.com]

The Status of U.S. and European Government Funding for Synthetic Biology

The U.S. has invested over two and a half times more than the EU and three European countries.
The genome of the synthetic cell was designed in the computer and brought to life through chemical synthesis

First Replicating Cell Driven by Synthetic Genome Created by Venter Institute

Team’s next step is to generate the smallest possible viable genome.
Alliance will enable technology improvements and better efficiencies.

DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from Gene Synthesis to...

Companies believe that the alliance will enable technology improvements and better efficiencies.

Takara Bio Taps University of Pennsylvania to Help Advance HIV Gene Therapy into U.S....

The company and Carl H. June, M.D., will jointly conduct preclinical studies and regulatory steps required for completion of an IND.

Ark Pulls MAA Covering Gene-Based Therapy for Brain Cancer

With EMEA’s request for a new trial of Cerepro for operable malignant glioma, company is evaluating the potential of a takeover.

$25M NSF Center Set Up to Investigate Complex Biological Systems

MIT, University of Illinois at Urbana-Champaign, and Georgia Tech will run the facility.

Gene-Synthesis Firms Set Up Biosecurity Protocol

Blue Heron Biotechnology, DNA2.0, GeneArt, GenScript, and Integrated DNA Technologies have created the International Gene Synthesis Consortium (IGSC).

Sigma-Aldrich and Sangamo Biosciences Broaden Agreement Related to Zinc-Finger Technology

Sigma-Aldrich and Sangamo BioSciences enacted an expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA...

DNA2.0 Reveals Intricacies Involved in Optimized Gene Design

Firm reports in PLoS ONE the identification of codon-choice design principles that allow greater protein expression.

Scientists Create Targeted Knockout Rats Using Sangamo’s Zinc Finger Nuclease Technology

Rats had permanent, heritable gene mutations, which will help scientists develop novel genetically modified animal models of human disease.